Page last updated: 2024-12-08

iridomyrmecin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

iridomyrmecin: produced by the Drosophila parasitoid Leptopilina heterotoma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Heterotomagenus[no description available]CampanulaceaeA plant family of the order Campanulales, subclass Asteridae, class Magnoliopsida[MeSH]

Cross-References

ID SourceID
PubMed CID442427
CHEBI ID5967
SCHEMBL ID1649438
MeSH IDM0577344

Synonyms (21)

Synonym
iridomyrmexin
iridomyrmecin
C09786 ,
485-43-8
AC1L9CSW ,
(4s,4as,7s,7ar)-4,7-dimethyl-4,4a,5,6,7,7a-hexahydro-1h-cyclopenta[c]pyran-3-one
nsc 10974
9736r92epu ,
cyclopenta(c)pyran-3(1h)-one, hexahydro-4,7-dimethyl-, (4s-(4alpha,4abeta,7beta,7abeta))-
(+)-iridomyrmecin
unii-9736r92epu
SCHEMBL1649438
CHEBI:5967
cyclopenta(c)pyran-3(1h)-one, hexahydro-4,7-dimethyl-, (4s,4as,7s,7ar)-
cyclopenta(c)pyran-3(1h)-one, hexahydro-4,7-dimethyl-, (4s-(4.alpha.,4a.beta.,7.beta.,7a.beta.))-
.alpha.-(2-hydroxymethyl-3-methylcyclopentane)propionic acid .delta.-lactone
iridomyrmecin [mi]
iridomyrmecin, (+)-
surecn1649438
DTXSID40876125
Q2016116
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
terpene lactone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.26 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]